Stammdaten
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Unternehmen & Branche
| Name | KAMADA LTD |
|---|---|
| Ticker | KMDA |
| CIK | 0001567529 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | B0L2CR900 |
|---|---|
| ISIN | USB0L2CR9009 |
| Typ | Common Stock |
| Marktkapitalisierung | 471,9 Mio. USD |
| Beta | 0,31 |
| Dividendenrendite | 0,03 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 603,622 | 0 | 603,622 | 427,993,282 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 839,298 | 0 | 839,298 | 5,925,444 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 196,954 | 0 | 196,954 | 1,390,496 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 167,521 | 0 | 167,521 | 1,182,698 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 157,610 | 0 | 157,610 | 1,112,727 | Neu | +100,0% | |
| Huntleigh Advisors, Inc. | 149,374 | 0 | 149,374 | 1,054,580 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 140,682 | 0 | 140,682 | 993,215 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 116,631 | 0 | 116,631 | 827,090 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 68,398 | 0 | 68,398 | 482,889 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 57,278 | 0 | 57,278 | 404,383 | Neu | +100,0% | |
| UBS Group AG | 55,329 | 0 | 55,329 | 390,623 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 39,664 | 0 | 39,664 | 280,028 | Neu | +100,0% | |
| BlackRock, Inc. | 38,448 | 0 | 38,448 | 271,443 | Neu | +100,0% | |
| Man Group plc | 34,294 | 0 | 34,294 | 242,116 | Neu | +100,0% | |
| Aristides Capital LLC | 33,015 | 0 | 33,015 | 233,086 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 29,409 | 0 | 29,409 | 207,627 | Neu | +100,0% | |
| Quadrature Capital Ltd | 21,889 | 0 | 21,889 | 154,536 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 21,160 | 0 | 21,160 | 149,389 | Neu | +100,0% | |
| SIH Partners, LLLP | 19,024 | 0 | 19,024 | 134,309 | Neu | +100,0% | |
| XTX Topco Ltd | 14,566 | 0 | 14,566 | 102,836 | Neu | +100,0% | |
| Ruggaard & Associates LLC | 12,524 | 0 | 12,524 | 88,419 | Neu | +100,0% | |
| MORGAN STANLEY | 12,411 | 0 | 12,411 | 87,622 | Neu | +100,0% | |
| EWA, LLC | 11,249 | 0 | 11,249 | 79,418 | Neu | +100,0% | |
| CITY NATIONAL BANK OF FLORIDA /MSD | 10,132 | 0 | 10,132 | 71,532 | Neu | +100,0% | |
| Focus Partners Wealth | 10,000 | 0 | 10,000 | 70,600 | Neu | +100,0% | |
| China Universal Asset Management Co., Ltd. | 9,399 | 0 | 9,399 | 66,357 | Neu | +100,0% | |
| BARCLAYS PLC | 4,788 | 0 | 4,788 | 33,803 | Neu | +100,0% | |
| CITIGROUP INC | 1,611 | 0 | 1,611 | 11,424 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 1,267 | 0 | 1,267 | 9,000 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 1,244 | 0 | 1,244 | 8,783 | Neu | +100,0% | |
| GF FUND MANAGEMENT CO. LTD. | 1,133 | 0 | 1,133 | 7,999 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 700 | 0 | 700 | 4,942 | Neu | +100,0% | |
| ACADIAN ASSET MANAGEMENT LLC | 314,021 | 0 | 314,021 | 2,221 | Neu | +100,0% | |
| Steward Partners Investment Advisory, LLC | 225 | 0 | 225 | 1,589 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 135 | 0 | 135 | 953 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 15 | 0 | 15 | 106 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 4 | 0 | 4 | 28 | Neu | +100,0% | |
| Daiwa Securities Group Inc. | 192 | 0 | 192 | 1 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 603,622 | 427,993,282 | 96.38 |
| RENAISSANCE TECHNOLOGIES LLC | 839,298 | 5,925,444 | 1.33 |
| MARSHALL WACE, LLP | 196,954 | 1,390,496 | 0.31 |
| GOLDMAN SACHS GROUP INC | 167,521 | 1,182,698 | 0.27 |
| MILLENNIUM MANAGEMENT LLC | 157,610 | 1,112,727 | 0.25 |
| Huntleigh Advisors, Inc. | 149,374 | 1,054,580 | 0.24 |
| TWO SIGMA INVESTMENTS, LP | 140,682 | 993,215 | 0.22 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 116,631 | 827,090 | 0.19 |
| CITADEL ADVISORS LLC | 68,398 | 482,889 | 0.11 |
| JPMORGAN CHASE & CO | 57,278 | 404,383 | 0.09 |
| UBS Group AG | 55,329 | 390,623 | 0.09 |
| BANK OF AMERICA CORP /DE/ | 39,664 | 280,028 | 0.06 |
| BlackRock, Inc. | 38,448 | 271,443 | 0.06 |
| Man Group plc | 34,294 | 242,116 | 0.05 |
| Aristides Capital LLC | 33,015 | 233,086 | 0.05 |
| GEODE CAPITAL MANAGEMENT, LLC | 29,409 | 207,627 | 0.05 |
| Quadrature Capital Ltd | 21,889 | 154,536 | 0.03 |
| JANE STREET GROUP, LLC | 21,160 | 149,389 | 0.03 |
| SIH Partners, LLLP | 19,024 | 134,309 | 0.03 |
| XTX Topco Ltd | 14,566 | 102,836 | 0.02 |